TECHPRECISION CORP (TPCS): Nasdaq/NYSE listing notice — TechPrecision receives Nasdaq late-filing notice; says deficiency cured with Q3 10-Q filing

TECHPRECISION CORP

Received Nasdaq notice on Feb 26, 2024 for failure to timely file Q3 10-Q by Feb 20 extended deadline.
Company filed the overdue Q3 10-Q on March 1, 2024 and expects Nasdaq to accept this as curing the deficiency.
Nasdaq allowed 60 days to submit compliance plan; can grant exception until Aug 12, but company expects no further action.
Press release issued March 1 announcing receipt of notice and the subsequent filing.

item 3.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

TECHPRECISION CORP received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).

Exchange: nasdaq
Notice: noncompliance notice
Deficiency: late filing
Rules: 5250(c)(1)

Exact text from the filing

February 26, 2024, TechPrecision Corporation (the “Company”) received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) because it had not timely filed its Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2023 (the “Q3 Form 10-Q”) with the Securities and Exchange Commission (the “SEC”) on or before February 20, 2024, the extended period provided for the filing under Rule 12b-25(b) of the Securities Exchange Act of 1934, as amended.

View on SEC.gov

94 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

TECHPRECISION CORP filing history →

Source: SEC EDGAR

accession 0001104659-24-029978

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.